echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Neurology: Risk comparison of seizure exacerbation in different epilepsy types before and after pregnancy: focal epilepsy may be exacerbated, especially frontal lobe epilepsy

    Neurology: Risk comparison of seizure exacerbation in different epilepsy types before and after pregnancy: focal epilepsy may be exacerbated, especially frontal lobe epilepsy

    • Last Update: 2022-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Previous studies have shown that seizure frequency in the first nine months of pregnancy is a good predictor of seizure frequency during pregnancy, although focal epilepsy syndromes and specific antiepileptic drug (ASM) treatment may be associated with worsening seizures during pregnancy probability correlation is stronger
    .


    These studies did not incorporate localization analyses and no details on ASM concentrations were available


    We investigated the effects of epilepsy type and seizure site, as well as ASM regimen and concentration, on seizure frequency during pregnancy and postpartum
    .

     We investigated the effects of epilepsy type and seizure site, as well as ASM regimen and concentration, on seizure frequency during pregnancy and postpartum
    .


    We investigated the effects of epilepsy type and seizure site, as well as ASM regimen and concentration, on seizure frequency during pregnancy and postpartum


    Clinical data were collected in Brigham and Women's Hospital's Longitudinal Prospective Database of Pregnant Women with Epilepsy
    .


    In each participant, baseline seizure frequency was calculated for pregnancies prior to 9 months, and it was determined whether seizure frequency increased during pregnancy or postpartum


    • Ninety-nine patients with a total of 114 pregnancies were included between 2013 and 2018
      .
    • Focal epilepsy was more frequent than generalized epilepsy during pregnancy (21.
      1% vs 5.
      3%, OR 4.
      70; 95% CI (1.
      00, 22.
      00); p=0.
      0497)
      .
    • Among patients with focal epilepsy, seizure frequency increased in patients with frontal lobe epilepsy (OR 8.
      00; 95% CI (2.
      19, 29.
      21); p=0.
      0017)
      .
    • There was no difference in the incidence of postpartum seizure exacerbations between focal and generalized (11.
      1% vs 9.
      1%, p=0.
      4478), frontal and other focal epilepsy (18.
      8% vs 6.
      0%; p=0.
      1478) groups
      .
    • Compared with monotherapy, pregnant women who received combined therapy had a higher odds of worsening epilepsy (OR=8.
      36, 95% CI=(2.
      07, 33.
      84), p=0.
      0029), regardless of medication or epilepsy type
      .
    • Lack of preconceived freedom from epilepsy was also associated with increased seizure frequency during pregnancy (OR=6.
      418; p=0.
      0076)
      .
  • Ninety-nine patients with a total of 114 pregnancies were included between 2013 and 2018
    .
  • Focal epilepsy was more frequent than generalized epilepsy during pregnancy (21.
    1% vs 5.
    3%, OR 4.
    70; 95% CI (1.
    00, 22.
    00); p=0.
    0497)
    .
  • Focal epilepsy was more frequent than generalized epilepsy during pregnancy (21.
    1% vs 5.
    3%, OR 4.
    70; 95% CI (1.
    00, 22.
    00); p=0.
    0497)
    .


    focal epilepsy
  • Among patients with focal epilepsy, seizure frequency increased in patients with frontal lobe epilepsy (OR 8.


    Women with focal epilepsy were more likely to experience worsening seizures during pregnancy than women with generalized epilepsy; the risk was especially high for frontal lobe epilepsy


    Voinescu PE, Ehlert AN, Bay CP, Allien S, Pennell PB.
    Variations in Seizure Frequency During Pregnancy and Postpartum by Epilepsy Type [published online ahead of print, 2021 Dec 10].
    Neurology.
    2021;10.
    1212/WNL.
    0000000000013056.
    doi: 10.
    1212/WNL.
    0000000000013056 Leave a message here
  • This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.